Topics

Dicerna Pharmaceuticals to Present at Upcoming Investor Conferences

16:49 EST 22 Feb 2019 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer of investigational ribonucleic acid interference (RNAi) therapeutics, today announced that Douglas M. Fambrough, Ph.D., president and chief executive office...

Other Sources for this Article

Rebecca Peterson
Head of Corporate Communications
Dicerna Pharmaceuticals, Inc.
Ph: 617-612-6325
rpeterson@dicerna.com

NEXT ARTICLE

More From BioPortfolio on "Dicerna Pharmaceuticals to Present at Upcoming Investor Conferences"

Quick Search

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

BioPortfolio - life science, medical devices and pharmaceutical conference
BioPortfolio is a leading news, information and knowledge resource covering the global life science industries impacted on by biotechnology. The site aims to provide the lay person, the researcher and the management executive with a single location to so...